Home > Research > Publications & Outputs > ADAMs family members as amyloid precursor prote...
View graph of relations

ADAMs family members as amyloid precursor protein -secretases.

Research output: Contribution to journalJournal articlepeer-review

<mark>Journal publication date</mark>1/11/2003
<mark>Journal</mark>Journal of Neuroscience Research
Issue number3
Number of pages11
Pages (from-to)342-352
Publication StatusPublished
<mark>Original language</mark>English


In the non-amyloidogenic pathway, the Alzheimer's amyloid precursor protein (APP) is cleaved within the amyloid- domain by -secretase precluding deposition of intact amyloid- peptide. The large ectodomain released from the cell surface by the action of -secretase has several neuroprotective properties. Studies with protease inhibitors have shown that -secretase is a zinc metalloproteinase, and several members of the adamalysin family of proteins, tumour necrosis factor- convertase (TACE, ADAM17), ADAM10, and ADAM9, all fulfil some of the criteria required of -secretase. We review the evidence for each of these ADAMs acting as the -secretase. What seems to be emerging from numerous studies, including those with mice in which each of the ADAMs has been knocked out, is that there is a team of zinc metalloproteinases able to cleave APP at the -secretase site. We also discuss how upregulation of -secretase activity by muscarinic agonists, cholesterol-lowering drugs, steroid hormones, non-steroidal anti-inflammatory drugs, and metal ions may explain some of the therapeutic actions of these agents in Alzheimer's disease.